What is Wegovy Weight Loss?

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy contains semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that was first approved for diabetes management before being repurposed for chronic weight management. The medication works by slowing stomach emptying and activating brain regions that control appetite, helping patients achieve meaningful weight reduction. Understanding how semaglutide functions can help you decide if this treatment aligns with your health goals.

How Semaglutide Reduces Appetite and Body Weight

Semaglutide mimics a natural hormone your gut produces after eating, signaling fullness to your brain even when you consume smaller portions. This mechanism reduces hunger intensity and food cravings throughout the day, making it easier to maintain a calorie deficit without constant willpower. Clinical trials show that patients on semaglutide lose 15-22% of their starting body weight over 68 weeks, compared to 2-3% with diet and exercise alone.

The medication also slows how quickly food moves through your stomach, extending feelings of fullness between meals. This dual action—both brain-based appetite suppression and digestive slowdown—creates a sustained reduction in calorie intake. Many patients report that their relationship with food shifts within the first few weeks, as intense cravings naturally diminish.

Semaglutide vs. Wegovy: Understanding the Difference

Wegovy is the brand name for semaglutide manufactured by Novo Nordisk and marketed specifically for weight loss, while semaglutide itself is the active pharmaceutical compound used across multiple approved products. The difference is not in the medication's effectiveness but in the brand, formulation concentration, and how it is marketed to patients. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, which contain the same active ingredient at a lower cost at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Compounded semaglutide follows the same quality and safety standards as brand-name Wegovy but may offer more flexibility in dosing schedules and pricing without insurance requirements. Both brand and compounded versions require a prescription from a licensed healthcare provider and ongoing medical supervision to ensure safety and efficacy.

Typical Dosing Schedule and Weight Loss Timeline

Semaglutide treatment begins with a low starting dose, typically 0.25 mg weekly, and increases gradually every four weeks to minimize digestive side effects and allow your body to adapt. Most patients reach an effective maintenance dose between 1.0 mg and 2.4 mg weekly, though individual responses vary based on metabolism and tolerance. Your dose may need to go up, but your price won't—PlexusDx charges a flat monthly rate regardless of dose level.

Meaningful weight loss typically appears within 4-8 weeks, with the most significant reductions occurring between weeks 12 and 24 of consistent treatment. Research demonstrates that patients who continue semaglutide for a full year lose an average of 15-18% of their body weight, with some achieving 20%+ reductions. Results accelerate when combined with structured nutrition changes and regular physical activity, as the medication removes the hunger barrier that often derails traditional dieting.

Side Effects and Safety Considerations

The most common side effects of semaglutide are gastrointestinal, including nausea, vomiting, constipation, and diarrhea, which typically peak during dose increases and diminish as your body adjusts over 1-2 weeks. Starting at the lowest dose and increasing slowly, staying hydrated, and eating smaller meals help minimize these symptoms for most patients. Serious side effects are rare but can include pancreatitis, gallbladder problems, and dehydration, which is why ongoing medical monitoring through PlexusDx is essential.

Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not use semaglutide, as animal studies suggested increased thyroid cancer risk. Women who are pregnant, breastfeeding, or planning pregnancy should discontinue semaglutide at least two months before conception. Discussing your full medical history with a PlexusDx provider ensures semaglutide is safe and appropriate for your individual health profile.

Genetic Factors That Influence Your Weight Loss Response

Your genetic makeup significantly influences how effectively semaglutide works for you, as variations in appetite-regulation genes determine how strongly your brain responds to GLP-1 signals. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 pathways and 49 peptides to identify how genetic variants in GLP1R, GIPR, FTO, and MC4R affect your weight loss potential. Understanding your genetic predispositions allows PlexusDx providers to personalize your treatment plan, potentially combining semaglutide with complementary compounds or lifestyle strategies that target your specific biology.

Patients carrying certain genetic variants may experience faster weight loss, fewer side effects, or benefit from combination therapy with tirzepatide or other peptides. The Precision Peptide test costs $99 as an add-on after your first month of treatment and provides insights into 150+ genetic markers relevant to metabolic health. This data-driven approach transforms weight loss from trial-and-error dieting into a precision medicine strategy tailored to your unique biochemistry.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide from PlexusDx as effective as brand-name Wegovy?

Yes, compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and works through the same biological mechanisms as Wegovy. The primary difference is cost and convenience—PlexusDx charges a flat $189/mo starting price without insurance requirements, while Wegovy often costs $300+ monthly with insurance or cash pay. Both require a doctor's prescription and ongoing medical oversight.

How much weight can you realistically expect to lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use PlexusDx semaglutide in all 50 states without insurance?

Yes, PlexusDx serves all 50 states and requires no insurance or membership fees—semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat. Treatment is HSA/FSA eligible, and PlexusDx providers handle all prescription and medical oversight requirements.

What happens to weight loss if you stop taking semaglutide?

Weight regain typically occurs within weeks to months after discontinuing semaglutide, as appetite hormones return to pre-treatment levels and hunger signals resume. Research suggests most patients regain 50% of lost weight within one year of stopping, though those who maintain dietary changes lose weight more slowly than those who resume old eating patterns. This is why semaglutide is considered a long-term or ongoing therapy rather than a short-term fix.

How does the PlexusDx Precision Peptide Genetic Test improve semaglutide outcomes?

The test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R to reveal how your body responds to appetite-suppressing signals, predicting semaglutide effectiveness and optimal dosing. Patients with favorable genetic profiles may experience faster weight loss or fewer side effects, while others may benefit from combination therapy or alternative compounds. At $99 after your first month, the test transforms treatment from guesswork into precision medicine aligned with your biology.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.